MIST
Milestone Pharmaceuticals Inc
0.8157$
-5.8%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | 100.0% | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | 525.0% | – | – | – | 2.2% | 29.4% | 5.7% | 6.9% | |
| – | – | – | – | – | -525.0% | – | – | – | 100.0% | 70.6% | 94.3% | 94.6% | |
| – | – | – | – | – | 3,648.1% | – | – | – | 357.1% | 1,411.8% | 627.7% | 700.1% | |
| – | – | – | – | – | 3,704.6% | – | – | – | 328.9% | 2,026.9% | 4,051.5% | 1,527.7% | |
| – | – | – | – | – | 11,433.3% | – | – | – | 1,216.2% | 10,058.8% | 4,679.2% | 3,447.6% | |
| – | – | – | – | – | -11,433.3% | – | – | – | -1,116.2% | -9,988.2% | -4,585.0% | -3,353.0% | |
| – | – | – | – | – | 850.9% | – | – | – | 63.7% | 1,737.4% | 845.3% | 461.5% | |
| – | – | – | – | – | -11,447.2% | – | – | – | -1,126.1% | -10,997.9% | -5,118.8% | -3,593.4% | |
| – | – | – | – | – | -60.2% | – | – | – | -6.1% | -45.8% | – | – | |
| – | – | – | – | – | -11,447.2% | – | – | – | -1,126.1% | -10,952.1% | -5,118.8% | -3,585.6% | |
| – | – | – | – | – | -10,572.2% | – | – | – | -1,060.2% | -9,237.0% | -4,263.3% | -3,124.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.